TRNAU1AP

Across TCGA pan-cancer cohorts, TRNAU1AP Mutation is linked to patient survival in 4 of 34 cancer types, making it a survival-associated TRNAU1AP data layer compared with 25 for mass-spec protein and 7 for mass-spec protein.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher TRNAU1AP Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated TRNAU1AP expression acts as an unfavorable survival marker.

HNSC, KICH, and PRAD are the cancer types where TRNAU1AP Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Median	II,III,IV	0.059	0.712	<.001	45	view →
KICH	DFS	Median	All	0.035	0.904	<.001	30	view →
PRAD	DFS	Median	All	0.085	0.774	<.001	6	view →
LUSC	OS	Median	All	0.011	0.819	<.001	6	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

TRNAU1AP–HNSC (OS)

Open the HNSC breakdown →